gavel_istock-517976804_avosb-
Avosb / iStockphoto.com
9 February 2018Americas

Gilead sued over HIV treatment

ViiV Healthcare, which was established by major pharma companies, has filed a patent infringement complaint against Gilead Sciences in a case involving an HIV treatment drug.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
9 October 2017   Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir.

More on this story

Biotechnology
9 October 2017   Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir.

More on this story

Biotechnology
9 October 2017   Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir.